Evidence map›Paper›PMID 41553508›Full record

ArticleDermatologie (Heidelberg, Germany)2026

[Skin damage caused by optical radiation beyond UV].

Wolfgang Bäumler, Mark Berneburg

Abstract readEnglish Abstract
PubMed Publisher
In one paragraph

Article in Dermatologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Wolfgang BäumlerKlinik und Poliklinik für Dermatologie, Universitätsklinikum Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Deutschland. wolfgang.baeumler@klinik.uni-regensburg.de.
Mark BerneburgKlinik und Poliklinik für Dermatologie, Universitätsklinikum Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Along with other environmental factors, ultraviolet radiation (UV-B, UV-A) definitely plays a role in skin aging and skin cancer. Recently, it has been shown that visible light and infrared radiation are also involved in the skin aging process. Visible light in the blue-green spectral range can be absorbed by certain molecules of the skin in a similar way to UV-A, thereby generating reactive oxygen species (ROS). Light in this spectral range can trigger erythema and an increase in pigmentation, possibly also inducing the expression of matrix metalloproteinases (MMP) such as MMP‑1 and, thus, contributing to visible skin aging. In contrast, visible light in the red spectral range can have the opposite effect, reducing erythema and periorbital rhytides (photorejuvenation). Radiation in the near-infrared spectral range (IR-A) penetrates deep into the skin and can increase the temperature in the skin through absorption in water, thereby altering cell activities. IR‑A radiation can be absorbed by biomolecules such as cytochrome c oxidase in the mitochondria of fibroblasts, where it triggers a significant increase in ROS. This results in a retrograde signaling cascade toward the cell nucleus and the expression of many genes, including MMP‑1. Under IR‑A, collagen formation also declines and angiogenesis occurs. All of these effects of IR‑A contribute to skin aging. Protective filters for the skin, such as those used for UVR radiation, are not available for IR and visible light. The use of creams containing antioxidants or iron oxide pigments could offer some protection in these spectral ranges.

Indexed as

Infrared RaysLightSkinSkin AgingUltraviolet RaysErythemaHumansReactive Oxygen SpeciesSkin NeoplasmsReactive Oxygen SpeciesHeatMatrix metalloproteinasesReactive oxygen speciesSkin agingSkin cancer

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.